InMed Pharmaceuticals Inc.

INM · NASDAQ
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Assets
Cash & Equivalents$11,076$6,572$8,913$7,951
Short-Term Investments$0$0$0$58
Receivables$465$353$260$113
Inventory$961$1,244$1,616$3,206
Other Curr. Assets$365$521$542$1,026
Total Curr. Assets$12,867$8,690$11,332$12,355
Property Plant & Equip (Net)$992$1,250$723$1,164
Goodwill$0$0$0$0
Intangibles$1,621$1,783$1,946$2,715
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$100$100$105$227
Total NC Assets$2,713$3,133$2,775$4,106
Other Assets$0$0$0$0
Total Assets$15,580$11,823$14,106$16,461
Liabilities
Payables$370$626$544$1,501
Short-Term Debt$436$318$376$520
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,034$1,028$1,081$2,252
Total Curr. Liab.$1,840$1,972$2,001$4,273
LT Debt$306$645$16$501
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$306$645$16$501
Other Liabilities$0$0$0$0
Cap. Leases$741$963$392$1,022
Total Liabilities$2,146$2,617$2,017$4,775
Equity
Pref Stock$0$0$0$0
Common Stock$91,221$82,784$77,620$91,034
Retained Earnings-$117,238-$109,076-$101,400-$120,300
AOCI$129$129$129$166
Other Equity$39,323$35,369$35,741$40,786
Total Equity$13,434$9,206$12,090$11,687
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$15,580$11,823$14,106$16,461
Net Debt-$10,335-$5,609-$8,521-$6,930
InMed Pharmaceuticals Inc. (INM) Financial Statements & Key Stats | AlphaPilot